Citrate regional anticoagulation in continuous renal replacement therapy (CRRT) is a relatively recent technique, which was developed to reduce the complications of anticoagulation in critically ill patients at high risk of bleeding. Citrate anticoagulation was demonstrated to reduce the bleeding and the overall complication rate in critically ill patients on CRRT, without shortening circuit survival. Citrate anticoagulation is the only anticoagulation technique that demonstrated to reduce mortality in critically ill patients with acute kidney injury, when compared with other techniques. With technological improvement and development of more reliable protocols and management algorithms, citrate could become the first choice for anticoagulation during CRRT in critically ill patients.

Citrate anticoagulation to reduce mortality in patients needing continuous renal replacement therapy

Cabrini L.
2016-01-01

Abstract

Citrate regional anticoagulation in continuous renal replacement therapy (CRRT) is a relatively recent technique, which was developed to reduce the complications of anticoagulation in critically ill patients at high risk of bleeding. Citrate anticoagulation was demonstrated to reduce the bleeding and the overall complication rate in critically ill patients on CRRT, without shortening circuit survival. Citrate anticoagulation is the only anticoagulation technique that demonstrated to reduce mortality in critically ill patients with acute kidney injury, when compared with other techniques. With technological improvement and development of more reliable protocols and management algorithms, citrate could become the first choice for anticoagulation during CRRT in critically ill patients.
2016
9783319334295
9783319334271
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2087521
 Attenzione

L'Ateneo sottopone a validazione solo i file PDF allegati

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact